Page last updated: 2024-08-21

adamantane and s 1033

adamantane has been researched along with s 1033 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berger, D; Bernthaler, T; Eisenwort, G; Entner, M; Hadzijusufovic, E; Herrmann, H; Hoermann, G; Rülicke, T; Sadovnik, I; Stefanzl, G; Valent, P; Willmann, M	1

Other Studies

1 other study(ies) available for adamantane and s 1033

Article	Year
Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph Experimental hematology, 2018, Volume: 57 Topics: Adamantane; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Coculture Techniques; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Fibroblasts; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Neoplasm Proteins; Nitriles; Protein Kinase Inhibitors; Pyrimidines; Pyrrolidines; Tumor Cells, Cultured; Vildagliptin; Xenograft Model Antitumor Assays	2018

Article

Year

Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph

Experimental hematology, 2018, Volume: 57

Topics: Adamantane; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Coculture Techniques; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Fibroblasts; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Neoplasm Proteins; Nitriles; Protein Kinase Inhibitors; Pyrimidines; Pyrrolidines; Tumor Cells, Cultured; Vildagliptin; Xenograft Model Antitumor Assays

2018